Meropenem versus piperacillin-tazobactam for the treatment of pancreatic necrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Meropenem versus piperacillin-tazobactam for the treatment of pancreatic necrosis

Published:2024-06 Issue:2 Volume:109 Page:116209
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Racketa Savannah^ORCID,Gandhi Kelvin,Lambie Matthew

Publisher

Elsevier BV

Reference10 articles.

1. 2019 WSES guidelines for the management of severe acute pancreatitis;Leppäniemi;World J Emerg Surg,2019

2. Classification of acute pancreatitis–2012: revision of the Atlanta classification and definitions by international consensus;Banks;Gut,2013

3. Acute necrotizing pancreatitis: treatment strategy according to the status of infection;Büchler;Ann Surg,2000

4. American college of gastroenterology. American College of gastroenterology guideline: management of acute pancreatitis [published correction appears in Am J Gastroenterol. 2014 Feb;109(2):302];Tenner;Am J Gastroenterol,2013

5. American gastroenterological association clinical practice update: management of pancreatic necrosis;Baron;Gastroenterology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3